Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-line Cryoablation for Early Treatment of Persistent Atrial Fibrillation - a Randomized Study Comparing Early Trigger Isolation Using the Cryoballoon Versus Antiarrhythmic Medication

NCT05939076 is registered in ClinicalTrials.gov with Region Örebro County as lead sponsor.

NCT NCT05939076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05939076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-line Cryoablation for Early Treatment of Persistent Atrial Fibrillation - a Randomized Study Comparing Early Trigger Isolation Using the Cryoballoon Versus Antiarrhythmic Medication
Lead sponsor
Region Örebro County
Phase
Phase 3
Overall status
Not yet recruiting
Start date
August 21, 2023
Completion date
December 31, 2028
Enrollment
220 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, persistent